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Abstract

Author Manuscript

Exposure to early life adversity may disrupt the development and maturation of neurons and brain
circuits, which, in turn, underlie neurodevelopment and mental illnesses. During fetal life,
maternal adversity is conveyed to the developing brain via several molecular signals, including the
stress hormone corticotropin releasing hormone (CRH). Employing a large well characterized
prospective cohort, we find that fetal exposure to placental-origin CRH levels predicts structural
and functional brain outcomes in children. Specifically, elevated placental CRH levels portend
thinning of selective cortical regions of exposed individuals, with commensurate cognitive and
emotional deficits. Notably, the relations of placental-origin CRH to cortical thinning and
childhood symptoms are sex-specific. In view of the established effects of CRH on survival and
arborization of cortical neurons, these findings position placental CRH as an important mediator of
the consequences of early-life adversity on neuropsychiatric outcomes.
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Introduction
Exposure to early life adversity disrupts brain development resulting in altered brain
networks and structure (1–3). These structural changes are associated with functional
alterations that are often maintained throughout the lifespan, mediated by enduring
epigenetic modifications of gene expression (2–4). Indeed, enduring alterations of brain
structure and function at molecular, cellular and circuit levels (5,6) are considered
fundamental mechanisms of how early-life experiences influence health and disease (1–5).
In the aggregate, exposures to intrauterine and neonatal insults (7) and consequent altered
brain anatomy (8,9) and connectivity (10) contribute significantly to the global burden of
mental illness.

Author Manuscript

Specifically, early-life exposure to maternal stress and trauma is linked to subsequent
depression (11–13), posttraumatic stress disorder (PTSD), panic disorder, substance abuse,
abnormal stress response (13,14) and other serious disorders (2,3,11). Emerging evidence
suggests that exposure to early-life adversity may be causally related to brain changes
underlying the risk for psychopathology (7,15,16). Because the fetal period is unmatched by
any other in growth and development, this stage in the human life span is the most
vulnerable to both organizing and disrupting maternal signals.

Author Manuscript

Among the most salient signals shaping the human fetus is the stress hormone, corticotropicreleasing hormone (CRH). CRH, a 41-amino acid neuropeptide, is normally synthesized
primarily in the paraventricular nucleus of the hypothalamus and has a major role in
regulating pituitary-adrenal function and the physiological response to stress (17,18). CRH
synthesized and released in other brain regions such as hippocampus (19) and cortex (20,21)
contributes to the sculpting of neuronal dendritic development and maturation via its actions
on specific receptors that are located on dendritic spines Indeed, nanomolar concentrations
of CRH can excessively prune dendritic trees of developing rodent cortical neurons (22).
CRH of brain origin is not detectable in the circulation (23). However, during human
pregnancy, the CRH gene, located on the long arm of chromosome 8 (24), is expressed in the
human placenta and amniotic membrane (25,26). Placental CRH (pCRH) is released into the
maternal and fetal compartments as early as the eighth week of gestation and increases
exponentially across gestation to regulate fetal maturation (27), metabolic functions (28,29)
and the timing of birth (30).
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Placental CRH expression is responsive to a range of maternal stress signals, including
increased cortisol, norepinephrine and epinephrine, reduced uterine blood flow, and
infection (31–33). Thus, placental CRH represents an integrative pathway through which
diverse prenatal stressors inform the fetus of the state of its environment and shape fetal
developmental trajectories in preparation for life after birth (34,35). There are several reports
linking elevated human fetal exposure to pCRH including to decreased fetal startle and
habituation (27,36), delayed neonatal neuromotor development (37); increased infant fear
and distress (38); and prodromal markers of increased risk for affective disorders in young
children (39). Here, we demonstrate the potential consequences of fetal exposure to elevated
levels of CRH and identify putative mechanisms. Specifically, we find that higher levels of
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placental CRH are associated with cortical thinning in selective brain regions and with
decreased cognitive and emotional function in preadolescents.

Methods
All methods, human procedures and protocols were approved by the Institutional Review
Boards of the Universities of California-Irvine and Los Angeles, and Cedars-Sanai Hospital,
Los Angeles. Parents and children gave informed (or affirmed) consent for all aspects of the
protocol.
Participants

Author Manuscript

Ninety–seven mother/child dyads consented to participate in a longitudinal study of fetal
exposures to maternal stress hormones on child MRI (see Consort Diagram, Figure S1;
Tables S1A-1C). Women provided informed consent to provide a blood sample at five
intervals during gestation; 13.5–16.6 (M=15.3), 17.8–20.5 (M=19.2), 23.7–26.5 (M=24.9),
29.9–32.3 (M=30.9) and 34.6–38.1 (M=35.9). All women were English-speaking, healthy
adult (>18 years of age) pregnant women with singleton, intrauterine pregnancies. Subjects
were excluded if they had (i) multiple births, (ii) tobacco, alcohol, or other drug use in
pregnancy, (iii) uterine or cervical abnormalities, or (iv) presence of any conditions
associated with dysregulated neuroendocrine function. Their children (48 boys, 49 girls)
were enrolled at 6-9 years of age (M=7.3 ± 0.91). All participants provided written informed
consent after receiving a complete description of the study.
Assessments of pCRH in pregnant women

Author Manuscript

Gestational age at testing was determined by last menstrual period and was confirmed by
obstetric ultrasonographic biometry before 20 weeks. Maternal blood samples (20/ml) were
collected serially at five intervals throughout pregnancy by antecubital venipuncture into
siliconized ethylenediaminetetraacetic acid (EDTA) (purple top) vacutainers and then
immediately chilled to 60C. Samples were centrifuged at 2,000 g for 15 minutes, decanted
into polypropylene tubes prepared with aprotinin (Sigma Chemical, St. Louis, MO; 500
KIU/ml blood) and stored at −80°C until assayed.
pCRH determination

Author Manuscript

Following previously reported methods (40), the concentration of total maternal pCRH was
determined by radio-immunoassay (RIA; Bachem Peninsula Laboratories, San Carlos, CA).
The CRH assay had less than 0.01% cross-reactivity with ovine CRH, 36% cross-reactivity
with bovine CRH and non-detectable reactivity with human ACTH. The intra- and interassay coefficient of variance ranged from 5 to 15%, respectively. The minimum detectable
dose of the assay is 2.04 pg/ml (95% confidence interval; See Supplement for additional
assay details).
Data reduction for the RIA was conducted with a computer-assisted four-parameter logistics
program (41). Values exhibiting greater than 25% error (deviation from the standard curve)
were not included in the analyses. A subset of samples (n = 60) were sent to a clinical
laboratory (Quest Diagnostics) for further validation. The correlation between the two sets
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of data was 0.87 (p < .01). Shared variance between 19 and 31 weeks CRH samples was a
modest 14% (r=0.38). Mother/child dyads were recruited from two separate studies with
identical prenatal assessments. To ensure comparability between the cohorts for analysis, the
pCRH values were standardized within the two groups and then combined for statistical
analysis. (see Supplement for details). As expected, pCRH levels increased geometrically as
gestation advanced (Figure S4; Table S9).
Assessments in children

Author Manuscript

All children (ages 87.3 ± 10.9 mo) had a stable neonatal course (Median Apgar = 9, Range 8
to 10; GA at birth=39.2 ± 1.5 wks) and were without known neonatal illness or congenital,
chromosomal, or genetic anomalies. Participants had no evidence of neurological
abnormalities in the newborn period. Children’s structural MRI (sMRI) images were
assessed for normal anatomical appearance. Seven children with motion artifacts and three
children with abnormal scans were not included in the final sample (N=97). These ten
subjects did not differ from subjects providing useable scans (Table S8). At 6-9 years of age,
no physical conditions were reported by the parents in a structured interview format of the
MacArthur Health and Behavior Questionnaire (42). The majority (88%) of children were
right hand dominant (Edinburgh Handedness Inventory) (43).
Structural MRI (sMRI) Acquisition

Author Manuscript

The sMRI scan was acquired with a 3-T Philips Achieva system. Children were provided
earplugs and watched a movie while in the scanner to increase compliance and minimize
movement. A high resolution T1 anatomical scan was acquired in the sagittal plane with
1mm3 isotropic voxel dimensions. An Inversion-Recovery Spoiled Gradient Recalled
Acquisition (IR-SPGR) sequence with optimal parameters was applied: repetition rate (TR)=
11ms, echo time (TE)= 3.3ms, inversion time (TI)= 1100ms, turbo field echo factor (TFE)=
192, number of slices: 150, no SENSE acceleration, flip angle=180°, shot interval (time
from inversion pulse to the center of acquisition) = 2200ms. The images were reviewed by
the MRI operator (who was unaware of any of the study parameters) immediately after the
scan was completed. If there were visible signs of motion artifacts, the subject was asked to
stay for an additional scan. If the subject agreed, a second scan was acquired.
Processing of MRI data

Author Manuscript

Cortical surface reconstruction and volumetric segmentation was performed with the
FreeSurfer image analysis software suite (http://surfer.nmr.mgh.harvard.edu/). Streamlined
image processing procedures included; application of intensity normalization prior to
segmentation to minimize errors in identifying the boundaries (44); removal of non-brain
tissues (45); and transforming images into the Talairach space. Pial and white matter
surfaces were located by finding the highest intensity gradient. Surface inflation was applied
to each individual brain (46) and the inflated brains were registered to a spherical atlas.
Cortical thickness was the closest distance from the gray matter/white matter surface to the
pial surface at each vertex on the tessellated surface (47).
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Smoothing of images was done prior to regression. The command line interface was used for
FDR corrections and to accommodate more than one nuisance variable. Gestational age at
birth, birth weight, age of the child at testing, sex and handedness were included as
covariates. A threshold of p<0.05 was used for all statistical tests and outcomes were
corrected for multiple comparisons using False Discovery Rate (FDR).
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After FDR corrections and spatial normalization, the number of vertices that were
significantly associated with pCRH was determined in each region of the cortex. The
number of significant vertices for each area was added and divided by the total number of
vertices in that area to provide the percentage of the vertices that were significantly
associated with pCRH concentrations. The same procedure was computed for the number of
significant vertices in each lobe. For hemispheric and whole brain percentages, the
procedure was the same except the total number of subcortical vertices was subtracted from
the total.
Child Behavioral Analyses
We conducted a battery of tests that interrogate several brain regions and circuits, to obtain a
relatively broad assessment of cognitive and emotional function.
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The Child Behavior Checklist (CBCL) (48) is one of the most widely used parental
interviews for identifying affective and conduct disorder problems in children. Structured
interviews (rather than a questionnaire) were administered to mothers about the behavior of
their children. We focused on two inclusive scales; one that assessed Internalizing problems
(sum of anxious-depressed, withdrawn-depressed, and somatic-complaints scores) and the
other that evaluated externalizing problems (sums rule-breaking and aggressive behavior
problem scores). Responses were recorded on a Likert scale ranging from 0 = Not True, to 2
= Very True or Often True. Scores are summed and standardized scores are computed that
are age and sex-specific.
Reaction time to incongruent stimuli
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The “Flanker” is an executive function task that requires the ability to resolve conflicts when
competing information is present (49). Participants view five arrows arrayed horizontally on
a screen and are instructed to press a left or right response button based on the direction of
the center arrow (target). They are instructed to ignore the surrounding arrows which are
either congruent (all aligned in the same direction) or incongruent with the center arrow.
This task consists of 24 congruent trials and 24 incongruent trials. Each set of arrows is
presented until the child responds (maximum of 5000 msec) with a 750 msec inter-trial
interval. Among the scores median reaction time to targets with incongruent distractors
correlates most highly with other indexes of performance derived from this test (all r’s
>0.70). (The association between externalizing scores on the CBCL and the median reaction
time on the flanker test was not significant (r= 0.09, p=.41)
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RESULTS
Elevated CRH levels throughout gestation are associated with cortical thinning
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Significant associations between fetal exposure to pCRH averaged across gestation and areas
of cortical thinning in children were found as illustrated in the pial maps (Figure 1).
Children exposed to high levels of pCRH throughout fetal life exhibited significant thinning
in 12% of the whole cortical mantle (Table S2A). The anatomical distribution of the cortical
thinning associated with CRH exposure involved equally the left (LH, 12%) and right (RH,
11%) hemispheres (Table S2A). Regional analyses indicated that cortical thinning associated
with pCRH levels was primarily in the temporal (15%) and the frontal (16%) regions (Table
1). Figures 1B-D are illustrative scatterplots of the associations between total fetal exposure
to pCRH across gestation and cortical thinning in the frontal and temporal areas (all
significant p< 0.01-0.001). The representative scatterplots coupled with Table 1, highlight
the widespread association between fetal exposures to pCRH and regional cortical thinning,
which are most notable in temporal and frontal areas. Average concentrations of pCRH
across gestation or levels at any gestational interval did not associate with increased cortical
thickness either globally or in any cortical region (Table S2b). Focusing on two gestational
ages, 19 weeks (early, when pCRH production begins to accelerate) and 31 weeks (late, the
time strongly associated with preterm birth), we found that maternal levels of pCRH were
significantly associated with cortical thinning.
CRH levels early in gestation: regional cortical thinning and behavioral outcomes

Author Manuscript

Fetal exposure to pCRH early in gestation (19 weeks) was associated with significant
thinning of the frontal poles. The significant association between pCRH and cortical
thinning was bilateral, but strongest in the right (B=0.14, p<0.001; 78% of the structure)
compared with the left frontal pole (B=−6.88, p<0.05; 69% of the structure; Table S3). Pial
maps depict areas of significant thinning linked with fetal pCRH exposure early in gestation
(Figure 2A) and the scatterplots illustrate the regions of the frontal cortex with the strongest
association (Figures 2B-D). (Findings were essentially unchanged with log transformed
pCRH values, Table S5). Nearly identical associations were observed in a smaller subsample
(N=57) of children exposed to high pCRH levels measured even earlier, at 15 weeks of fetal
life (Figures S3A-D).
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Thinning of the frontal pole has been associated with externalizing behaviors (50) defined as
actions that direct energy outward and tend to harm others (51). We tested if the effects of
pCRH exposure on cortical thinning contributed to the development of these behaviors
(Figure 2E). Our model supported the belief that reduced cortical volume in the frontal pole,
associated with elevated fetal exposure to concentrations of pCRH at 19 weeks gestation,
contribute to externalizing symptoms in 6-9 year old children (indirect effect: 0.93; 95%
BCCI 0.17 to 2.05; p < .05). Neither internalizing problems nor reaction time on the flanker
task were associated with cortical thinning in this region.
CRH levels in late gestation: regional cortical thinning and cognitive outcomes
Exposure to elevated levels of pCRH later in gestation (31 weeks) was associated with
cortical thinning in the lateral temporal and paracentral regions (Figure 3A). The effect was

Am J Psychiatry. Author manuscript; available in PMC 2019 May 01.

Sandman et al.

Page 7

Author Manuscript

localized to the left paracentral region and bilateral in the temporal cortex. Remarkably, 98%
of the lateral surface of the right temporal pole and 66% of the left temporal pole were
significantly thinner in children exposed to high levels of pCRH at 31 weeks gestation
(Table S4). Scatterplots (Figure 3B-D) illustrate these regional associations (and similar
associations were observed at 25 weeks gestation in a smaller subsample [N=50]).
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Structures comprising the temporal cortex subserve numerous cognitive and emotional
functions. Temporal cortical thinning has been reported in individuals with attentional
deficits (52), especially in the right temporal pole (53) which is active in tasks requiring
attention to relevant stimulation (54). We employed a statistical model (55) to test if the
effects of exposure to pCRH late in prenatal life on cortical thinning contributed to
impairment of attention in 6-9 year olds. The model (Figure 3E) indicated that the reduced
right temporal pole volume associated with exposure to pCRH at 31 week gestation may
partially account for poorer performance on a visual processing and sustained attention test
(indirect effect: 42.11; 95% BCCI 4.27 to 128.31; p <0.01) (56,57).
Sex differences
Exploratory analyses suggest significant sex differences in the nature and degree of
association between pCRH levels and global as well as regional cortical thinning. At both 19
and 31 weeks gestation, the associations were stronger in girls (Figure S2). The association
between fetal exposure to pCRH at 19 weeks gestation and cortical thinning involved most
cortical areas in girls (Figure S2A) but minimal in boys (Figure S2B). The fetal exposure to
pCRH at 31 weeks affected cortical thinning globally in boys (Figure S2C) but locally in the
temporal pole in girls (Figure S2D; similar to the findings for the combined sexes).
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DISCUSSION
The principal and novel findings in these series of studies are that human fetal exposure to
pCRH, even at concentrations which are insufficient to initiate labor or early delivery, is
associated with regional cortical thinning and commensurate cognitive and emotional
problems in a sex-specific manner in school-age children. Notably, such problems often are
prodromal events that are associated with eventual neuropsychiatric outcomes.
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The human placenta expresses pCRH by the eighth week of gestation and concentrations of
pCRH increase geometrically as pregnancy advances to regulate the timing and onset of
labor and delivery (30,58). Indeed, extremely high levels of placental CRH, often a result of
adverse events during pregnancy, stimulate a cascade of events that result in pre-term labor
and delivery. Premature birth is a significant contributing factor to impaired neurological and
psychiatric outcomes. However, pCRH levels also rise in response to a variety of maternal
stresses, and the novel finding here is the profound consequence of fetal exposure to pCRH
at levels that are not associated with early delivery, in full-term school-age children.
Specifically, we identify pronounced thinning in discrete cortical areas with implications for
emotional and cognitive functions. Pronounced cortical thinning was associated with fetal
exposure to pCRH across gestation with some evidence of localization in prefrontal and
temporal poles. Examination of discrete gestational intervals clarified that prefrontal
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thinning was associated with exposure at early mid-gestation and thinning of the temporal
pole was associated with exposure later in gestation.
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Our findings raise the novel possibility that CRH is causally linked to cortical thinning,
rather than merely signifying the presence of a harsh, stressful milieu to the developing fetal
brain. A causal role for CRH in cortical thinning is supported by recent findings in an animal
model (22). Cortical volume is largely comprised of dendritic trees of cortical neurons
(22,59) and changes in dendritic arborization can be measured as volume loss in MR
imaging (60). Our recent experiments demonstrate that exposure of developing cortical
neurons to physiological levels of CRH results in a dose-dependent reduction and
impoverishment of dendritic arborization (22). In addition, both exposure to early postnatal
CRH in vivo (61) and to maternal stress signals (62,63) provokes similarly impoverished
dendritic trees in the hippocampus. Indeed, exposure to nanomolar levels of CRH has been
shown to reduce dendritic length and complexity via CRH receptor type 1 (64), which is
expressed on the dendrites (65,66). Eliminating the actions of endogenous CRH led to
exuberant dendritic trees both in transgenic mice lacking the CRH receptor and chronic
exposure of organotypic slice cultures to CRH receptor blockers (64,65). Thus, it appears
that the role of physiological levels of CRH is to modulate – perhaps in concert with
glucocorticoids (67,68)– neuronal dendritic development in the perinatal hippocampus and
neocortex.

Author Manuscript

The sex differences observed here are intriguing, and consistent with increased prevalence of
stress-related disorders in women compared to men, tendencies observed also in prepubertal
children (69). Our novel findings here suggest that sex-specific structural consequences of
early-life adversity and potentially of CRH may be most apparent in females and are
consistent with conclusions that females exposed to prenatal stress are more likely than
males to exhibit increased levels of anxiety, impaired executive function and neurological
markers associated with these behaviors (69).
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In summary, our findings uncover a novel and unexpected result of prenatal elevation of
pCRH: reduction in cortical volume in typically developing children, perhaps related to
stunting of normal neuronal growth, and consequent commensurate subtle but significant
emotional and cognitive impairments. The behavioral assessments were not a priori designed
for assessing the unexpected cortical thinning observed in the temporal lobes, and this
limitation should be addressed in future studies. Even when CRH levels are not sufficient to
trigger premature birth and children are born at term, fetuses exposed to increased levels of
pCRH carry less-well developed cortical neurons, apparent from extensive yet selective
areas of cortical thinning. The cortical thinning is biologically significant because it is
associated with both cognitive and emotional deficits.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1.

Pial maps (A) illustrating statistically significant areas of cortical thinning associated with
average prenatal levels of pCRH measured throughout gestation. Representative scatterplots
(B) r=0.37; (C) r=0.36; (D) r=0.26, all significant (p< 0.01-0.001), revealing the associations
between placental corticotropin releasing hormone (CRH) and cortical thinning in specific
cortical regions
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FIGURE 2.
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Pial maps (A) illustrating statistically significant areas of cortical thinning associated with
prenatal levels of pCRH at 19 weeks gestation. Representative scatterplots (B [r=.33, p=.
005] C [r=.25, p=.04], D [r=.40, p=.001]) of the significant associations between pCRH and
cortical thinning in cortical subregions. Model (E) of the indirect significant association
among prenatal concentrations of pCRH, child cortical thinning in the frontal pole and child
internalizing behavior. The values correponding to each path in the model are
unstandardized regression coefficients. The indirect effect was estimated with bootstrapping
(1000 samples with replacement).
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FIGURE 3.
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Pial maps (A) from FreeSurfer illustrating statistically significant areas of cortical thinning
associated with prenatal levels of pCRH at 31 weeks gestation. Representative scatterplots
(B [r=.29, p=.01] C [r=.37, p=.001], D [r=.48, p=.001]) of the significant associations
between pCRH and cortical thinning in cortical subregions. Model (E) of the indirect
association among prenatal concentrations of pCRH, child cortical thinning in the right
temporal pole and child reaction time to a behavioral challenge. The values correponding to
each path in the model are unstandardized regression coefficients. The indirect effect was
estimated with bootstrapping (1000 samples with replacement).
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Percentage of structures of the frontal and temporal lobes that are thinner in children exposed to placental
CRH averaged across gestation. The results are presented for the left and right hemisphere.
AVERAGE ACROSS GESTATION

Author Manuscript

LH Medial Surface Frontal

Percent of Structure

RH Medial Surface Frontal

Percent of Structure

Orbital Frontal

11

Orbital Frontal

19

Paracentral

43

Paracentral

14

LH Lateral Surface Frontal

Percent of Structure

RH Lateral Surface Frontal

Percent of Structure

Superior Frontal

13

Superior Frontal

44

Rostral Middle Frontal

12

Rostral Middle Frontal

14

Frontal Pole

41

Frontal Pole

33

Pars Triangularis

16

Pars Triangularis

21

Parsorbitalis

6

Parsorbitalis

5

Lateral Orbital Frontal

15

Lateral Orbital Frontal

25

Parsopercularis

9

Parsopercularis

22

Caudal Middle Frontal

4

Caudal Middle Frontal

23

Precentral

18

Precentral

20

Insula

11

Insula

8

LH Lateral Surface Temporal

Percent of Structure

RH Lateral Surface Temporal

Percent of Structure
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Superior Temporal

39

Superior Temporal

12

Transverse Temporal

0

Transverse Temporal

0

Middle Temporal

22

Middle Temporal

24

Post Sup Temp sulcus

16

Post Sup Temp sulcus

0

Inferior Temporal

3

Inferior Temporal

12

Fusiform

7

Fusiform

2

Parahippocampal

11

Parahippocampal

0

Entorhinal

31

Entorhinal

0

Temporal Pole

4

Temporal Pole

70
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